Of interest, during longitudinal tumor ctDNA monitoring, we discovered that one patient with recurrent USC lost genetic mutations originally identified in her primary uterine tumor, which had been considered “driver gene mutations” (i.e., TP53), while other “driver” mutations (i.e., PIK3CA) remained detectable in plasma. This evidence concerns the gene PIK3CA and neoplasm.